Novo Nordisk A/S

Good day and thank you for standing by. Welcome to the Q3 2026 Novo Earnings Conference call. At this time all participants are in a listen only mode. After the speaker's presentation there will be a question and answer session. To ask a question during the session you will need to press star 1 and 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question please press star 1 and 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Michael Novot, Head of Investor Relations. Please go ahead.

Thank you very much, operator. Welcome to the NOBO earnings call for the third quarter of 2026. My name is Michael Novot and I'm the Head of Investor Relations at NOBO. With me today I have CEO Mike Doustdar, EVP US Operations Jamey Millar, EVP International Operations Emil Kongshøj Larsen, EVP Research and Development and Chief Scientific Officer Martin Holst Lange, and Chief Financial Officer Karsten Munk Knudsen. All speakers will be available for the Q&A session. Today's call is being webcasted live, and a recording will be made available on our website. The call is scheduled to last one hour. Next slide, please.

The presentation is structured as outlined on slide 2. Please stand by while the speakers reconnect Please stand by while the speakers reconnect. And where we got disconnected? Please continue.